Ashley Gallagher is an assistant editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
Monkeypox Vaccine Modeling Study Results Provide Road Map for Vaccination
Investigators model 2 hypothetical cities as interconnected networks with a combined population of 100,000 bisexual, gay, and other men who have sex with men.
Pharmacy Students Tackle Culturally Competent Care at The Daniel K. Inouye College of Pharmacy
A diverse population and financial obstacles present unique challenges for pharmacists in Hawaii.
Panelists Discuss Effective Management and Considerations for Hemophilia A
Pharmacists can coordinate education programs for patients to normalize quality of life and minimize infusion-related pain.
GSK Releases Positive Study Results for New First-in-Class Tuberculosis Drug
GSK3036656 demonstrates early bactericidal activity with a low, once-daily oral dose after 14 days of treatment.
Additional Validation Checks Help Identify Consequential Residual Confounding
The implementation of negative control outcomes and a complementary cohort demonstrate an estimated beneficial effect that associated with an individual’s overall health.
Risk of Severe Breakthrough COVID-19 Is Low Among Vaccinated Individuals with HIV
Study results show that patients with moderate or severe immune suppression should be considered a priority for additional vaccine doses and risk-reduction strategies.
5 Genomic Subgroups Show Promise in Helping Predict Clinical Outcomes for CLL
Investigators believe the findings can refine predictions, after independent evaluation, by identifying different modes of genetic alteration.
Panelists Discuss Effective Management, Considerations for Hemophilia A
Pharmacists can coordinate educational programs for patients to normalize quality of life and minimize infusion-related pain.
Study Results Show Influenza Vaccination Is Priority for Children With Severe Epilepsy
The seasonal flu vaccine should be prioritized for those with SCN1A-positive Dravet syndrome, because of the likelihood of severe neurological symptoms and complications.
Curative-Intent Radiotherapy, IMPT Show More Benefits for Oropharyngeal Carcinoma
Analysis shows that the therapy is associated with a reduced acute toxicity burden associated with intensity-modulated radiation therapy.
Study: Nose Swabs Show Promise in Predicting Severity of RSV Hospitalization for Infants
Investigators find that despite the same quantity of respiratory syncytial virus and presentation, some of the samples demonstrated signs of greater damage to cells.
Study Results Show High Prevalence of COVID-19, Flu Co-Infections in 2021-2022 Season
Analysis of central Missouri discovers differences in co-infection occurrence between Delta and Omicron variants.
Study: FGFR mRNA Overexpression Occurs Frequently for Those With Cholangiocarcinoma
Investigators also confirmed that FGFR2 fusion–positive tumors have a higher expression of FGFR2 but were not associated with higher expression of FGFR1, FGFR3, or FGFR4.
Study: Overall Patient Survival Estimates for NSCLC Are Transferable From US to Canada
Under specific circumstances and criteria, they are adjustable to approximate OS in selected populations of Canadian patients who have advanced non–small cell lung cancer.
Study Results Show Psilocybin Reduces Depression but Is Associated With Adverse Effects
Analysis indicates that a 25-mg dose reduces the condition scores significantly more than a 1mg dose over a 3-week period, but the 10-mg dose did not yield the same results.
Study: Adherence to Recommended Lung Cancer Follow-Up Screening Remains Low
Improvement is seen with a higher suspicion of disease and extended timelines, analysis demonstrates.
Study: Inhibiting S100A9 Gene in Skin Cells Reduces Severity of Psoriasis, Psoriatic Arthritis
These show promise as markers to help identify individuals with the conditions and develop targeted therapeutic options.
Review Results Link HPV Infections With Pregnancy Outcomes
Analysis includes an overview of the epidemiology, expression, and treatment of human papillomavirus infections during both gestation and childhood.
Epidural Nerve Blocking With Lidocaine Shows Promise in Treatment of Psoriatic Skin Lesions
Four individuals in a new study achieve improvement, with a 35% to 70% reduction in PASI scores.
CDC’s FluView Estimates Early Increases of Influenza Activity for 2022-2023 Season
Agency expects the highest level of activity in the south-central and Southeast areas of the United States.
Bristol Myers Squibb’s Reblozyl Meets Primary Endpoints as First-Line Treatment of MDS
Phase 3 trial evaluated luspatercept-aamt and shows highly statistically significant and clinically meaningful improvement in red blood cell transfusion for those with myelodysplastic syndromes.
Initiation of Antiretroviral Therapy Reduces Number of Active HIV-Infected Cells
ART also results in a faster decay of plasma HIV RNA and increased HIV CD8+T cell immunity compared with the treatment alone, investigators found.
Real-World Results of Gilead’s Biktarvy Show Long-Term Efficacy, Safety Profile
New clinical outcomes from BICSTaR study indicate sustained impact of the therapy for individuals with HIV.
Capivasertib Plus Faslodex Meets Both Primary Endpoints in Phase 3 Trial for Breast Cancer
Results demonstrate improved progression-free survival in the overall patient population and in a prespecified biomarker subgroup of tumors with alterations in specific genes, AstraZeneca says.
Study: COVID-19 Vaccine Does Not Raise Immune Toxicity Risk for Those Treated With ICI
Findings are encouraging for individuals with cancer who are receiving immune checkpoint inhibition treatment and want to get a third vaccine dose, investigators said.
Novartis’ Iptacopan Meets 2 Endpoints for Paroxysmal Nocturnal Hemoglobinuria Treatment
Phase 2 APPLY-PNH trial shows positive results superiority vs anti-C5 treatment in adult patients with PNH with residual anemia despite prior therapy.
Analysis Shows Positive Data for Moderna’s Omicron BA.1-Targeting Vaccine
Study results indicate durable immune response from bivalent booster after 3 months of follow-up.
Study Results Show Olfactory Dysfunction Due to COVID-19 May Last for More Than a Year
Highest prevalence is seen among adults, outpatients, and women and can cause persistent severe anosmia or hyposmia, findings indicate.
Study: Children With HIV Show Greater Risk for Impaired Neurological Development
News research results in Zambia also find that early intervention in the form of antiretroviral therapies and better nutrition may help close the gap.
Study: Adherence to PrEP Increases Prevention of HIV
However, lack of access and awareness about pre-exposure prophylaxis, medication cost, and underestimating disease risk are all barriers to PrEP.
2 Clarke Drive Cranbury, NJ 08512